Proinflammatory cytokines in serum and cerebrospinal fluid of CIDP patients

Neurological Research

Volumn 34, Issue 9, 2012, Pages 842-846

  Rentzos, Michael ^a   Angeli, Aikaterini V ^a   Rombos, Antonis ^a   Kyrozis, Andreas ^a   Nikolaou, Chryssoula ^a   Zouvelou, Vassiliki ^a   Dimitriou, Aikaterini ^a   Zoga, Margarita ^a   Evangelopoulos, Maria Eleni ^a   Tsatsi, Alexandra ^a   Tsoutsou, Anthousa ^a   Evdokimidis, Ioannis ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

CIDP; ELISA; IL 12; IL 15; IL 17; Th 1 immunity

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROLOGIC DISEASE; TH1 CELL; TH17 CELL;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DISABILITY EVALUATION; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84867906444     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000074     Document Type: Article

References (39)

1. Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci. 1994;127:170-178.
2. Rizzuto N, Morbin M, Cavallaro T, Ferrari S, Fallahi M, Galiazzo Rizzuto S. Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP). Acta Neuropathol (Berl.). 1998;96:603-609.
3. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin-17-producing CD4z effect T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-1132.
4. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006;18:349-356.
5. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006;177:566-573.
6. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000;165:6107-6115.
7. Dodon MD, Li Z, Hamaia S, Gazzolo L Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells. J Gen Virol. 2004;85:1921-1932.
8. Grabstein KH, Eisenmann J, Shanebeck K, Rauch C, Srinivasan S, Fung V, et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994;264:965-968.
9. Jonuleit H, Wiedemann K, Muller G, Degwert J, Hoppe U, Knop J, et al. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells. J Immunol. 1997;160:2610-2615.
10. Lee YB, Satoh J, Walker DG, Kim SU. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport. 1996;7:1062-1066.
11. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol. 1996;156:735-741.
12. Carson WE, Giri JG, Lindemann M, Linett ML, Ahdieh M, Paxton R, et al. IL-15 is a novel cytokine that activates human NK cells via components of IL-2 receptor. J Exp Med. 1994;180:1395-1403.
13. Blanco-Jerez C, Plaza JF, Masjuan J, Orensanz LM, Alvarez-Cermeño JC. Increased levels of IL-15 mRNA in relapsing-remitting multiple sclerosis attacks. J Neuroimmunol. 2002;128:90-94.
14. Losy J, Niezgoda A, Zaremba J. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol. 2002;40:151-153.
15. Rentzos M, Cambouri C, Rombos A, Nikolaou C, Anagnostouli M, Tsoutsou A, et al. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci. 2006;241:25-29.
16. Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Tsoutsou A, et al. Circulating interleukin-15 in dementia disorders. J Neuropsych Clin Neurosci. 2007;19:318-325.
17. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, et al. Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med. 1992;176:1387-1398.
18. Ryffel B. Interleukin-12: role of interferon-c in IL-12 adverse effects. Clin Immunol Immunopathol. 1997;83:18-29.
19. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, et al. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of interferon gamma in vivo. Int Immunol. 1994;6:157-167.
20. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, et al. Interleukin-12 profoundly upregulates the synthesis of antigen-specific complement-fixing IgG2a,IgG2b, IgG3 antibody-subclasses in vivo. Eur J Immunol. 1995;25:823-829.
21. Leonard GP, Waldburger KE, Goldman SJ. Prevention of autoimmune encephalomyelitis by antibodies against IL-12. J Exp Med. 1995;181:381-386.
22. Sivieri S, Ferrarini AM, Lolli F, Matà S, Pinto F, Tavolato B, et al. Cytokine pattern in the CSF from patients with GBS and CIDP. J Neurol Sci. 1997;147:93-95.
23. Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Naldi P, Molinari R, et al. The expression pattern of inflammatory mediators in CSF differentiates GBS from CIDP. Cytokine. 2010;51:138-143.
24. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol. 1993;47:55-61.
25. Mei FJ, Ishizu T, Murai H, Osoegawa M, Minohara M, Zhang KN, et al. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J Neurol Sci. 2005;228:75-85.
26. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. J Peripher Nerv Syst. 2010;15:1-9.
27. Pelidou SH, Zou LP, Deretzi G, Nennesmo I, Wei L, Mix E, et al. Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats. Scand J Immunol. 2000;51:29-35.
28. Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RD, Peakman M, Gregson N, et al. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2009;80:333-338.
29. Wu Y, Wang H-B, Wang W-Z. A study of associated cellmediated immune mechanisms in experimental autoimmune neuritis rats. J Neuroimmunol. 2007;185:87-94.
30. Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, Del Grande A, et al. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2009;14:107-117.
31. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593-2603.
32. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1-8.
33. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU, et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kB- and PI3-kinase/Aktdependent pathways. Arthritis Res Ther. 2004;6:R120-R128.
34. Jovanovic DV, Martel-Pelletier J, Di Battista JA, Mineau F, Jolicoeur FC, Benderdour M, et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum. 2000;43:1134-1144.
35. Prause O, Bozinovski S, Anderson GP, Lindén A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax. 2004;59:313-317.
36. Trajkovic V, Stosic-Grujicic S, Samardzic T, Markovic M, Miljkovic D, Ramic Z, et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J Neuroimmunol. 2001;119:183-191.
37. Miljkovic D, Trajkovic V. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 2004;15:21-32.
38. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345-350.
39. Vladić A, Horvat G, Vukadin S, Sucić Z, Simaga S. Cerebrospinal fluid and serum protein levels of TNF-alpha, IL-6 and soluble IL-6 receptor (sIL-6R gp80) in multiple sclerosis patients. Cytokine. 2002;20:86-89.